· Mainboard · NSE, BSE
Price Band
₹42–45
Lot Size
333 shares
Issue Size
₹139 Cr
Min. Investment
₹14,985
Indicative, updates through the day
Cap price plus current GMP: ₹45 — arithmetic, not a forecast
Hexagon Nutrition IPO is a Mainboard issue that listed on NSE, BSE on 12 June 2026. The issue price band is fixed at ₹42–₹45 per equity share with a minimum market lot size of 333 shares, bringing the total issue size to ₹139 Cr. At the upper price band, the minimum retail application requires one lot amounting to ₹14,985.
No meaningful grey market premium is actively quoted for Hexagon Nutrition IPO at this stage. For a Mainboard issue at this point in the timeline, this is standard until anchor book allocations and institutional bids build volume. A missing premium is not negative sentiment; it reflects lower off-market liquidity. Read our complete guide to IPO GMP mechanics.
As per the latest exchange feeds from BSE and NSE, Hexagon Nutrition IPO has been subscribed 53.68x overall — with QIB at 19.77x, NII at 161.49x, bNII at 183.16x, sNII at 118.15x, Retail at 26.85x, representing over 7,71,182 retail and institutional applications. When the retail category is oversubscribed, SEBI regulations mandate that allotment is determined via an automated computerized lottery where each valid PAN gets one equal chance.
The minimum investment for retail investors is one lot of 333 shares (approx. ₹14,985 at the cut-off price), while the maximum retail bid is capped at 13 lots (under ₹2,00,000). Applications must be submitted using ASBA via Net Banking or the UPI Mandate route through registered stockbrokers (Zerodha, Groww, Angel One, Upstox).
The official registrar appointed for this issue is KFin Technologies Ltd., with the basis of allotment finalised on 10 June 2026 and listing completed on 12 June 2026. Once declared, you can check your allotment status on our IPO Allotment Checker using your PAN or Application Number. If you are not allotted shares, the ASBA block on your bank funds is automatically released by T+2 day.
Issue Price
₹45
Listed At
₹53.19
Current Price
₹53.19
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods. The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports. Its product portfolio is classified into three segments: Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence. The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025. Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.
Hexagon Nutrition IPO raises ₹41.66 crore from anchor investors. Hexagon Nutrition IPO Anchor bid date is June 4, 2026.
| Category | Shares Offered | % |
|---|---|---|
| QIB | 1,54,29,851 | 50% |
| − Anchor Investor | 92,57,696 | 30% |
| − QIB (Ex. Anchor) | 61,72,155 | 20% |
| NII (HNI) | 46,28,956 | 15% |
| − bNII > ₹10L | 30,85,971 | 10% |
| − sNII < ₹10L | 15,42,985 | 5% |
| Retail | 1,08,00,897 | 35% |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 333 | ₹14,985 |
| Retail (Max) | 13 | 4329 | ₹1,94,805 |
| S-HNI (Min) | 14 | 4662 | ₹2,09,790 |
| S-HNI (Max) | 66 | 21978 | ₹9,89,010 |
| B-HNI (Min) | 67 | 22311 | ₹10,03,995 |
EPS (Pre IPO)
1.98
EPS (Post IPO)
2.93
ROE
12.12%
P/E (Pre IPO)
22.69
P/E (Post IPO)
15.35
Price / Book
2.48
Market Cap
₹553Cr.
| Company | P/E | ROE | Revenue |
|---|---|---|---|
| Sai Parenteral's Ltd. | 72.19 | ₹408.79 Cr | |
| Corona Remedies Ltd. | 43.47 | ₹655.37 Cr | |
| Rubicon Research Ltd. | 55.75 | ₹1,377.50 Cr | |
| Amanta Healthcare Ltd. | 34.59 | ₹126.00 Cr | |
| Anlon Healthcare Ltd. | 17.67 | ₹121.03 Cr | |
| Bio Medica Laboratories Ltd. | 13.03 | ₹52.43 Cr |
Hexagon Nutrition Ltd. Address
KFin Technologies Ltd.